InvestorsHub Logo
Followers 59
Posts 1898
Boards Moderated 1
Alias Born 12/10/2019

Re: None

Wednesday, 09/14/2022 8:44:09 AM

Wednesday, September 14, 2022 8:44:09 AM

Post# of 148
News: Source: Business Wire

bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, today announced publication of its research in high-throughput flow cytometry analysis of sputum. The journal PLOS ONE, published Sputum analysis by flow cytometry; an effective platform to analyze the lung environment reporting on results of analyzing sputum by flow cytometry as the basis for high-throughput diagnostic tests to determine the health of the lung.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIAF News